Hinge Health, Inc.
Hinge Health, Inc. (HNGE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HNGE · as of Jun 8, 2026
Key Statistics
Explore Hinge Health, Inc. Data
hnge stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 100.0%
The HNGE analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $65.82, representing +3.46% upside from the current price of $63.62.
Competitors & Peers
hnge competitorsHNGE
AKRO
CRNX
DYN
IMVT
INDVStock Performance
Full HistoryAbout Hinge Health, Inc.
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabili…
what is hinge health, inc. · hnge stock overview · hinge health, inc. company profile · who is hinge health, inc. ceo · hnge NYSE · hinge health, inc. headquarters · hinge health, inc. business segments
About Stock Overview & Key Data
Hinge Health, Inc. (HNGE) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NYSE since May 22, 2025. As of the latest trading session, HNGE stock price is $63.62, with a market capitalization of $4.9B. The stock has returned +67.42% over the past 12 months and +36.96% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Hinge Health, Inc. stock is Buy, with an average 12-month price target of $65.82. In fiscal year 2025, Hinge Health, Inc. reported revenue of $587.9M and net income of -$528.3M. For detailed data — including Hinge Health, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hinge Health, Inc. (HNGE) stock price is $63.62. The stock is traded on NYSE under the ticker symbol HNGE. The 52-week range is $30.08 – $66.55.